Abstract
The advent of the post genomics era coupled with advances in proteomics presents unprecedented opportunities for expedited discovery of microbial targets for subsequent development of novel modalities for management of infectious diseases. Here, we review a new application of proteomics called Proteomics-based Expression Library Screening (PELS). This functional proteomics tool permits rapid definition of comprehensive microbial immunoproteomes (microbial proteins expressed in vivo that elicit and interact with the host humoral immune response), a subset of which have excellent potential as diagnostic, drug and vaccine targets. PELS is a platform technology that is applicable to any sequenced pathogen. It offers several advantages over existing methods for global identification of immunogenic microbial proteins, and is both a rapid alternative and an adjunct to emerging protein antigen array/chip technologies.
Keywords: Proteomics, pathogen specific-markers, immunogenic, diagnostic, drug-target, vaccine
Current Proteomics
Title: Proteomics-Based Expression Library Screening (PELS): A Functional Proteomics Tool for Rapid Discovery of Immunogenic Pathogen-Specific Markers of Host Infection
Volume: 5 Issue: 1
Author(s): Indira T. Kudva and Manohar John
Affiliation:
Keywords: Proteomics, pathogen specific-markers, immunogenic, diagnostic, drug-target, vaccine
Abstract: The advent of the post genomics era coupled with advances in proteomics presents unprecedented opportunities for expedited discovery of microbial targets for subsequent development of novel modalities for management of infectious diseases. Here, we review a new application of proteomics called Proteomics-based Expression Library Screening (PELS). This functional proteomics tool permits rapid definition of comprehensive microbial immunoproteomes (microbial proteins expressed in vivo that elicit and interact with the host humoral immune response), a subset of which have excellent potential as diagnostic, drug and vaccine targets. PELS is a platform technology that is applicable to any sequenced pathogen. It offers several advantages over existing methods for global identification of immunogenic microbial proteins, and is both a rapid alternative and an adjunct to emerging protein antigen array/chip technologies.
Export Options
About this article
Cite this article as:
Kudva T. Indira and John Manohar, Proteomics-Based Expression Library Screening (PELS): A Functional Proteomics Tool for Rapid Discovery of Immunogenic Pathogen-Specific Markers of Host Infection, Current Proteomics 2008; 5 (1) . https://dx.doi.org/10.2174/157016408783955137
DOI https://dx.doi.org/10.2174/157016408783955137 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization
Current Medicinal Chemistry Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Current Protein & Peptide Science Hyaluronidase Inhibitors: A Biological and Therapeutic Perspective
Current Medicinal Chemistry Post-Stroke Immunodepression and Infection: An Emerging Concept
Infectious Disorders - Drug Targets Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Prospects and Limitations of T Cell Receptor Gene Therapy
Current Gene Therapy Intracellular Aβ and its Pathological Role in Alzheimer’s Disease: Lessons from Cellular to Animal Models
Current Alzheimer Research Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Current Pharmaceutical Design Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment
Recent Patents on Anti-Cancer Drug Discovery Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics The Tachykinergic System as Avenues for Drug Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Melatonin in Cardiac Ischemia/Reperfusion-Induced Mitochondrial Adaptive Changes
Cardiovascular & Hematological Disorders-Drug Targets Cardiopulmonary Interactions in Children with Heart Failure
Current Cardiology Reviews Role of Nitric Oxide and Reactive Oxygen Species in Arthritis
Current Pharmaceutical Design Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children
Current Drug Safety Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Drug Delivery Letters